Just diagnosed with Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus hub →Overview
Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus is a rare condition. Also known as Furukawa-Takagi-Nakao syndrome. Tomeko brings together the specialists, research, clinical trials, treatments and community for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:2579 · OMIM 158500 · ICD-10 G11.1 · GARD 0002417
Find care for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus
- Find a specialist or center for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus
- Search recruiting clinical trials for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus
- Open the interactive Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus hub — care near you, live trials & community
Authoritative references for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus
Research & market landscape for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus
Following Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus — the real-world landscape behind the condition, in one place.
- Latest Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus research on PubMed ↗
- Recruiting Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus trials on ClinicalTrials.gov ↗
- Explore the Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus and every rare condition. See how Tomeko works with industry →
Common questions
What is Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus?
Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus is a rare condition. Also known as Furukawa-Takagi-Nakao syndrome. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus together in one place.
What are the symptoms of Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus?
Symptoms of Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus.
How is Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus treated?
Treatment for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus, and review current options with them.
What causes Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus — is it genetic?
The cause and inheritance of Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus can explain what it means for you and your family.
I was just diagnosed with Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus, filtered to your area.
Are there clinical trials for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus?
Tomeko shows live, recruiting studies for Muscular atrophy, ataxia, retinitis pigmentosa, and diabetes mellitus from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- Acetazolamide-responsive myotonia
- Acquired porencephaly
- Actin accumulation myopathy
- Action myoclonus-renal failure syndrome
- Acute disseminated encephalomyelitis
- Acute disseminated encephalomyelitis with anti-MOG antibodies
- Acute disseminated encephalomyelitis without anti-MOG antibodies
- Acute encephalopathy with biphasic seizures and late reduced diffusion
